The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited

Authors:

Lee D, Gladwell D, Batty AJ, Brereton N and Tate E.

Publication type:

Journal article

Publication name:

Paediatric drugs

Citation:

Lee D, Gladwell D, Batty AJ, Brereton N and Tate E. The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited. Paediatr Drugs. 2013; 15(2):151-62.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies